ADMA ADMA Biologics Inc

3.09
-0.26  -8%
Previous Close 3.35
Open 3.31
Price To book 1.92
Market Cap 53154934
Shares 17,202,244
Volume 31,222
Short Ratio 1.75
Av. Daily Volume 65,624

SEC filingsSee all SEC filings

  1. CT ORDER - Confidential treatment order 171080807
  2. S-8 - Securities to be offered to employees in employee benefit plans 171041602
  3. 10-Q - Quarterly report [Sections 13 or 15(d)] 171025550
  4. 8-K - Current report 171025311
  5. 8-K - Current report 17993360

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued July 29 2016. Third-party manufacturing isses cited. Noted June 27, 2017 its intention to refile BLA in mid-2018.
RI-002
Primary Immune Deficiency Diseases